Glucosuric, renal and haemodynamic effects of licogliflozin, a dual inhibitor of sodium‐glucose co‐transporter‐1 and sodium‐glucose co‐transporter‐2, in patients with chronic kidney disease: A randomized trial-Reference-Cited by-同舟云学术

Glucosuric, renal and haemodynamic effects of licogliflozin, a dual inhibitor of sodium‐glucose co‐transporter‐1 and sodium‐glucose co‐transporter‐2, in patients with chronic kidney disease: A randomized trial

Published:2021-02-16 Issue:5 Volume:23 Page:1182-1190
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

He YanLing¹^ORCID,Pachori Alok¹,Chen Ping¹,Ma Shenglin¹,Mendonza Anisha E.¹,Amer Ahmed²,Marbury Thomas C.³,Hinder Markus⁴

Affiliation:

1. Novartis Institutes for BioMedical Research Cambridge Massachusetts USA

2. Novartis Pharmaceuticals Corporation East Hanover New Jersey USA

3. Orlando Clinical Research Center Orlando Florida USA

4. Novartis Institutes for BioMedical Research Basel Switzerland

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14327

Reference34 articles.

1. Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes

2. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

3. Chronic kidney disease: global dimension and perspectives

4. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

5. Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes;Cochrane Database of Systematic Reviews;2024-05-21

2. Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease;Frontiers in Endocrinology;2022-05-19

3. The roles of sodium and volume overload on hypertension in chronic kidney disease;Kidney Research and Clinical Practice;2021-12-31

4. A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease;Drugs;2021-08-07